No Increase in Insulin Antibodies and No Clear Evidence of Transfer of Insulin Aspart Across the Placenta in Pregnant Women with Type 1 Diabetes.

The article focuses on a randomized, controlled study of a rapid-acting insulin analog in pregnant women with Type 1 diabetes where the development of insulin antibodies (AB) was assessed. It has been found that levels of AB were similar between insulin aspart (IAsp) and human insulin (HI) groups. There is also a lack of clear evidence of transfer of IAsp across the placenta.